Welcome to Enduring

33 matches found
Availability Dates Title Credit Hours
May 26, 2020 - May 31, 2021 2020 Virtual Meeting: Comorbidities and MS: Critical Thinking about DMT's and Vaccines 1.00 
May 27, 2020 - May 31, 2021 2020 Virtual Meeting: Current Perspectives of Pediatric Care and Research 1.00 
May 29, 2020 - May 31, 2021 2020 Virtual Meeting: The Role of Biological Aging In MS Progression 1.00 
May 29, 2020 - May 31, 2021 2020 Virtual Meeting: The Role of Complement in MS 1.00 
May 26, 2020 - May 31, 2021 2020 Virtual Meeting: Whitaker Lecture: CNS Immune Responses that Underlie Progressive MS: Future Challenges in the COVID-19 Era 1.00 
May 29, 2020 - May 31, 2021 2020 Virtual Meeting: A Clinician's Guide to Cognition in MS 1.00 
May 28, 2020 - May 31, 2021 2020 Virtual Meeting: Cannabis and MS: Efficacy, Safety, Drug Interactions, and Research Update 1.00 
May 29, 2020 - May 31, 2021 2020 Virtual Meeting: Caring for Women Across the Reproductive Lifespan 1.00 
May 27, 2020 - May 31, 2021 2020 Virtual Meeting: Depression and MS: Diagnosing and Treating 1.00 
May 28, 2020 - May 31, 2021 2020 Virtual Meeting: Emerging Therapies Across the Disease Spectrum 1.00 
May 29, 2020 - May 31, 2021 2020 Virtual Meeting: Genetics Update 1.00 
May 27, 2020 - May 31, 2021 2020 Virtual Meeting: Importance of Assessing Nutritional Health in Patients with MS 1.00 
May 28, 2020 - May 31, 2021 2020 Virtual Meeting: John F. Kurtzke Lecture: Stem Cell Research Update 1.00 
May 26, 2020 - May 31, 2021 2020 Virtual Meeting: Neuromyelitis Optica Spectrum Disorders: Emerging Treatment Options 1.00 
May 26, 2020 - May 31, 2021 2020 Virtual Meeting: Progressive MS: Diagnosis, Clinical Course and Long-Term Management 1.00 
May 27, 2020 - May 31, 2021 2020 Virtual Meeting: Rehabilitation in MS: That was Then, This is Now 1.00 
May 26, 2020 - May 31, 2021 2020 Virtual Meeting: Science, Art, and Practice of Behavioral Medicine 1.00 
May 28, 2020 - May 31, 2021 2020 Virtual Meeting: Use of Psychotropics in MS: Antidepressants, Antianxiety Agents, Mood Stabilizers, Hypnotics, Antipsychotics, and Cognitive Enhancers 1.00 
February 24, 2020 - February 25, 2021 A 30‐Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes 1.00 
June 1, 2020 - June 1, 2021 Clinically Assessed Walking Capacity Versus Real-World Walking Performance in People with Multiple Sclerosis 1.00 
January 28, 2020 - January 29, 2021 Counseling Women with MS in Middle Age and the Postmenopausal Years 1.00 
October 1, 2019 - October 1, 2020 Experience of Identity Change in People Who Reported a Diagnosis of Multiple Sclerosis: A Qualitative Inquiry 1.00 
December 1, 2019 - December 1, 2020 How Can We Apply Guidelines in the Rapidly Changing MS Treatment Landscape? 1.00 
August 20, 2019 - August 1, 2020 Perspectives About Time Frames in Stem Cell Research for Multiple Sclerosis: "Time Is Brain" 1.00 
February 1, 2020 - February 1, 2021 Perspectives of People with Multiple Sclerosis About Helminth Immunotherapy 1.00 
April 1, 2020 - April 2, 2021 Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis 1.50 
February 1, 2020 - February 28, 2021 Reproductive Health Planning For Patients With Multiple Sclerosis (Supplement) 1.00 
December 12, 2019 - December 31, 2020 Reproductive Health Planning for Patients with Multiple Sclerosis: A Clinician's Guide (Webinar) 1.00 
November 30, 2019 - November 30, 2020 Stabilization without Rituximab after Disease Activation in an Alemtuzumab-Treated Patient with Multiple Sclerosis and a Literature Overview 1.00 
February 19, 2020 - February 21, 2021 The Art of Multiple Sclerosis Therapies: Applying Immunologic Principles in MS 2.00 
July 8, 2020 - July 31, 2021 The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies 1.00 
June 1, 2020 - June 1, 2021 The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis 1.25 
December 1, 2019 - December 1, 2020 Toward Digital Self-monitoring of Multiple Sclerosis: Investigating First Experiences, Needs, and Wishes of People with MS 0.75 
Back To Top

Connect

Connect on Facebook LinkedIn RSS twitter